111 related articles for article (PubMed ID: 12767072)
1. Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study.
Dumeaux V; Alsaker E; Lund E
Int J Cancer; 2003 Jul; 105(6):844-50. PubMed ID: 12767072
[TBL] [Abstract][Full Text] [Related]
2. Use of oral contraceptives, alcohol, and risk for invasive breast cancer.
Dumeaux V; Lund E; Hjartåker A
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1302-7. PubMed ID: 15298950
[TBL] [Abstract][Full Text] [Related]
3. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study.
Lund E; Bakken K; Dumeaux V; Andersen V; Kumle M
Int J Cancer; 2007 Aug; 121(3):645-8. PubMed ID: 17372914
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
[TBL] [Abstract][Full Text] [Related]
6. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
Lidegaard O
Acta Obstet Gynecol Scand; 1997 Mar; 76(3):252-60. PubMed ID: 9093141
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptive use by formulation and endometrial cancer risk among women born in 1947-1964: The Nurses' Health Study II, a prospective cohort study.
Burchardt NA; Shafrir AL; Kaaks R; Tworoger SS; Fortner RT
Eur J Epidemiol; 2021 Aug; 36(8):827-839. PubMed ID: 33331993
[TBL] [Abstract][Full Text] [Related]
8. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
9. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk.
Maxwell GL; Schildkraut JM; Calingaert B; Risinger JI; Dainty L; Marchbanks PA; Berchuck A; Barrett JC; Rodriguez GC
Gynecol Oncol; 2006 Nov; 103(2):535-40. PubMed ID: 16740300
[TBL] [Abstract][Full Text] [Related]
10. Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study.
Busund M; Bugge NS; Braaten T; Waaseth M; Rylander C; Lund E
Int J Cancer; 2018 Jun; 142(11):2293-2302. PubMed ID: 29349773
[TBL] [Abstract][Full Text] [Related]
11. Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study.
Kumle M; Weiderpass E; Braaten T; Persson I; Adami HO; Lund E
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1375-81. PubMed ID: 12433714
[TBL] [Abstract][Full Text] [Related]
12. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Lancet; 1997 Apr; 349(9060):1202-9. PubMed ID: 9130941
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.
Fournier A; Berrino F; Riboli E; Avenel V; Clavel-Chapelon F
Int J Cancer; 2005 Apr; 114(3):448-54. PubMed ID: 15551359
[TBL] [Abstract][Full Text] [Related]
14. Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer.
Strom BL; Berlin JA; Weber AL; Norman SA; Bernstein L; Burkman RT; Daling JR; Deapen D; Folger SG; Malone KE; Marchbanks PA; Simon MS; Ursin G; Weiss LK; Spirtas R
Contraception; 2004 May; 69(5):353-60. PubMed ID: 15105056
[TBL] [Abstract][Full Text] [Related]
15. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
16. Review: oral contraceptives and menopausal estrogens in relation to breast neoplasia.
Brzezinski A; Schenker JG
Isr J Med Sci; 1982 Apr; 18(4):433-8. PubMed ID: 7045033
[TBL] [Abstract][Full Text] [Related]
17. Sex steroids and breast cancer prevention.
Spicer DV; Pike MC
J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
[TBL] [Abstract][Full Text] [Related]
18. Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus.
Bernatsky S; Clarke A; Ramsey-Goldman R; Joseph L; Boivin JF; Rajan R; Moore AD; Leung MH; Allen A; Gordon C
Rheumatology (Oxford); 2004 Sep; 43(9):1178-81. PubMed ID: 15226516
[TBL] [Abstract][Full Text] [Related]
19. Menopausal hormone usage and breast cancer in Saskatchewan: a record-linkage cohort study.
Risch HA; Howe GR
Am J Epidemiol; 1994 Apr; 139(7):670-83. PubMed ID: 8166128
[TBL] [Abstract][Full Text] [Related]
20. [Estrogen replacement therapy and breast cancer].
Bakken K; Alsaker E; Eggen AE; Lund E
Tidsskr Nor Laegeforen; 2005 Feb; 125(3):282-5. PubMed ID: 15702147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
